{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:44:52Z","timestamp":1792673092102,"version":"4.5.0"},"reference-count":25,"publisher":"BMJ","issue":"12","funder":[{"DOI":"10.13039\/100001540","name":"CHEST Foundation","doi-asserted-by":"publisher","award":["Not applicable"],"award-info":[{"award-number":["Not applicable"]}],"id":[{"id":"10.13039\/100001540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001540","name":"CHEST Foundation","doi-asserted-by":"publisher","award":["Research Grant in Pulmonary Fibrosis"],"award-info":[{"award-number":["Research Grant in Pulmonary Fibrosis"]}],"id":[{"id":"10.13039\/100001540","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Air pollution exposure is associated with disease severity, progression and mortality in patients with idiopathic pulmonary fibrosis (IPF). Combined impacts of environmental and socioeconomic factors on outcomes in patients with IPF are unknown. The objectives of this study were to characterise the relationships between relative environmental and social disadvantage with clinical outcomes in patients with IPF.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Patients with IPF were identified from a longitudinal database at University of California, San Francisco. Residential addresses were geocoded and linked to the CalEnviroScreen 3.0 (CES), a tool that quantifies environmental burden in California communities, combining population, environmental and pollution vulnerability into individual and composite scores (higher scores indicating greater disadvantage). Unadjusted and adjusted linear and logistic regression and Fine and Gray proportional hazards models were used.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>603 patients were included. Higher CES was associated with lower baseline forced vital capacity ( \u03b2 =\u22120.073, 95% CI \u22120.13 to \u22120.02; p=0.006) and diffusion capacity of the lung for carbon monoxide ( \u03b2 =\u22120.11, 95% CI \u22120.16 to \u22120.06; p&lt;0.001). Patients in the highest population vulnerability quartile were less likely to be on antifibrotic therapy (OR=0.33; 95% CI 0.18 to 0.60; p=0.001) at time of enrolment, compared with those in the lowest quartile. An association between CES and mortality was suggested, but sensitivity analyses demonstrated inconsistent results. Relative disadvantage of the study cohort appeared lower compared with the general population.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Higher environmental exposures and vulnerability were associated with lower baseline lung function and lower antifibrotic use, suggesting that relative socioenvironmental disadvantage has meaningful impacts on patients with IPF.<\/jats:p><\/jats:sec>","DOI":"10.1136\/thoraxjnl-2021-217652","type":"journal-article","created":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T18:28:27Z","timestamp":1640284107000},"page":"1237-1242","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":22,"title":["Relative environmental and social disadvantage in patients with idiopathic pulmonary fibrosis"],"prefix":"10.1136","volume":"77","author":[{"given":"Na'ama","family":"Avitzur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M","family":"Noth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mubasiru","family":"Lamidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven D","family":"Nathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold R","family":"Collard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison M","family":"DeDent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeta","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1205-5511","authenticated-orcid":false,"given":"Kerri A","family":"Johannson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,12,23]]},"reference":[{"key":"2023100202050724000_77.12.1237.1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201807-1255ST"},{"key":"2023100202050724000_77.12.1237.2","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1164\/rccm.201905-0958LE","article-title":"Trends in idiopathic pulmonary fibrosis-related mortality in the United States: 2000-2017","volume":"200","author":"Dove","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2023100202050724000_77.12.1237.3","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201404-145OC"},{"key":"2023100202050724000_77.12.1237.4","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/152.4.307"},{"key":"2023100202050724000_77.12.1237.5","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00397-2017","article-title":"The association between air pollution and the incidence of idiopathic pulmonary fibrosis in northern Italy","volume":"51","author":"Conti","year":"2018","journal-title":"Eur Respir J"},{"key":"2023100202050724000_77.12.1237.6","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00122213"},{"key":"2023100202050724000_77.12.1237.7","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2017-209967"},{"key":"2023100202050724000_77.12.1237.8","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01877-2020","article-title":"Nitrogen dioxide increases the risk of mortality in idiopathic pulmonary fibrosis","volume":"57","author":"Yoon","year":"2021","journal-title":"Eur Respir J"},{"key":"2023100202050724000_77.12.1237.9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.chest.2018.01.015","article-title":"Air pollution exposure is associated with lower lung function, but not changes in lung function, in patients with idiopathic pulmonary fibrosis","volume":"154","author":"Johannson","year":"2018","journal-title":"Chest"},{"key":"2023100202050724000_77.12.1237.10","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.chest.2017.07.034","article-title":"Exposure to ambient particulate matter is associated with accelerated functional decline in idiopathic pulmonary fibrosis","volume":"153","author":"Winterbottom","year":"2018","journal-title":"Chest"},{"key":"2023100202050724000_77.12.1237.11","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-018-3407-0","article-title":"Disparities in pulmonary fibrosis care in the United States: an analysis from the nationwide inpatient sample","volume":"18","author":"Gaffney","year":"2018","journal-title":"BMC Health Serv Res"},{"key":"2023100202050724000_77.12.1237.12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2005.01205.x"},{"key":"2023100202050724000_77.12.1237.13","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2021.106415","article-title":"Low income and outcome in idiopathic pulmonary fibrosis: an association to uncover","volume":"183","author":"Ses\u00e9","year":"2021","journal-title":"Respir Med"},{"key":"2023100202050724000_77.12.1237.14","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s40572-015-0069-5","article-title":"Socioeconomic disparities and air pollution exposure: a global review","volume":"2","author":"Hajat","year":"2015","journal-title":"Curr Environ Health Rep"},{"key":"2023100202050724000_77.12.1237.15","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.2009-040GL"},{"key":"2023100202050724000_77.12.1237.16","first-page":"646","article-title":"Idiopathic pulmonary fibrosis: diagnosis and treatment","volume":"161","year":"2000","journal-title":"International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med"},{"key":"2023100202050724000_77.12.1237.17","unstructured":"Faust JAL , Bangia K , Galaviz V , et al . Update to the California communities environmental health screening tool, CalEnviroScreen 3.0. 2017, 2017."},{"key":"2023100202050724000_77.12.1237.18","doi-asserted-by":"publisher","DOI":"10.2307\/2670170"},{"key":"2023100202050724000_77.12.1237.19","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk","volume":"16","author":"Gray","year":"1988","journal-title":"The Annals of Statistics"},{"key":"2023100202050724000_77.12.1237.20","unstructured":"R Development Core Team . R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2013."},{"key":"2023100202050724000_77.12.1237.21","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-156-10-201205150-00004"},{"key":"2023100202050724000_77.12.1237.22","unstructured":"United States environmental protection agency national ambient air quality Standards. Available: http:\/\/www.epa.gov\/air\/criteria.html"},{"key":"2023100202050724000_77.12.1237.23","doi-asserted-by":"crossref","unstructured":"Dempsey TM , Payne S , Sangaralingham L . Adoption of the anti-fibrotic medications pirfenidone and nintedanib for patients with idiopathic pulmonary fibrosis. Ann Am Thorac Soc 2021.","DOI":"10.1513\/AnnalsATS.202007-901OC"},{"key":"2023100202050724000_77.12.1237.24","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201506-1063ST"},{"key":"2023100202050724000_77.12.1237.25","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S2213-2600(21)00046-1","article-title":"Geography, generalisability, and susceptibility in clinical trials","volume":"9","author":"Clougherty","year":"2021","journal-title":"Lancet Respir Med"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thoraxjnl-2021-217652","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T09:07:02Z","timestamp":1696237622000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thoraxjnl-2021-217652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,23]]},"references-count":25,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,11,15]]},"published-print":{"date-parts":[[2022,12]]}},"alternative-id":["10.1136\/thoraxjnl-2021-217652"],"URL":"https:\/\/doi.org\/10.1136\/thoraxjnl-2021-217652","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,23]]}}}